Search hospitals > Tennessee > Chattanooga
WR Clinsearch, LLC
Claim this profileChattanooga, Tennessee 37421
Global Leader in Migraine
Global Leader in Non-alcoholic Fatty Liver Disease
Conducts research for Fatty Liver Disease
Conducts research for Syndrome
Conducts research for Irritable Bowel Syndrome
142 reported clinical trials
3 medical researchers
Summary
WR Clinsearch, LLC is a medical facility located in Chattanooga, Tennessee. This center is recognized for care of Migraine, Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Syndrome, Irritable Bowel Syndrome and other specialties. WR Clinsearch, LLC is involved with conducting 142 clinical trials across 107 conditions. There are 3 research doctors associated with this hospital, such as Mark M McKenzie, MD, Obadias Marquez, MD, and Natasha Ballard, MD.Area of expertise
1Migraine
Global Leader2Non-alcoholic Fatty Liver Disease
Global Leaderstage 2
stage 3
Stage I
Top PIs
Mark M McKenzie, MDWR-ClinSearch, LLC3 years of reported clinical research
Studies Colorectal Cancer
Studies Obesity
15 reported clinical trials
17 drugs studied
Obadias Marquez, MDWR-Clinsearch, LLC1 year of reported clinical research
Studies Obesity
Studies Diabetes
6 reported clinical trials
8 drugs studied
Natasha Ballard, MDClinSearch, LLC1 year of reported clinical research
Studies COVID-19
Studies Coronavirus
3 reported clinical trials
5 drugs studied
Clinical Trials running at WR Clinsearch, LLC
Epilepsy
Migraine
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Seizures
Coronavirus
Asthma
Respiratory Syncytial Virus
Fatty Liver Disease
Diabetic Neuropathy
Cenobamate
for Focal Seizures
Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (≥18 years of age). In the US it is approved for use as monotherapy, however, there is little clinical data assessing its use as monotherapy in adults with POS. This study is designed to explore the effectiveness of doses of 100 mg/day and 200 mg/day as monotherapy in adult subjects with newly diagnosed or recurrent POS/focal onset epilepsy.
Recruiting3 awards Phase 41 criteria
BHV-7000
for Epilepsy
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of idiopathic generalized epilepsy with generalized tonic-clonic seizures and includes an additional open-label extension (OLE) phase.
Recruiting0 awards Phase 2 & 34 criteria
BHV-7000
for Epilepsy
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Recruiting0 awards Phase 2 & 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WR Clinsearch, LLC?
WR Clinsearch, LLC is a medical facility located in Chattanooga, Tennessee. This center is recognized for care of Migraine, Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Syndrome, Irritable Bowel Syndrome and other specialties. WR Clinsearch, LLC is involved with conducting 142 clinical trials across 107 conditions. There are 3 research doctors associated with this hospital, such as Mark M McKenzie, MD, Obadias Marquez, MD, and Natasha Ballard, MD.